Spectacular response of metastatic vulval Crohn's disease to infliximab treatment

Int J Dermatol. 2016 Oct;55(10):1146-8. doi: 10.1111/ijd.13209. Epub 2016 Jan 8.

Authors

Sophie Wylomanski¹, Réjane Bouquin², Brigitte Dréno³, Gaëlle Quéreux³

Affiliations

¹ Department of Gynecology and Obstetrics, Nantes University Hospital, Nantes, France. sophie.wylomanski@gmail.com.
² Department of Gynecology and Obstetrics, Nantes University Hospital, Nantes, France.
³ Skin Cancer Unit, Nantes University Hospital, INSERM 892, Nantes, France.

PMID: 26749393
DOI: 10.1111/ijd.13209

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Chemical and Drug Induced Liver Injury / etiology
Crohn Disease / complications
Crohn Disease / drug therapy*
Dermatologic Agents / adverse effects
Dermatologic Agents / therapeutic use*
Female
Humans
Infliximab / adverse effects
Infliximab / therapeutic use*
Treatment Outcome
Vulvar Diseases / drug therapy*
Vulvar Diseases / etiology

Substances

Dermatologic Agents
Infliximab